Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!

Malaria Vaccine Will Be an Expensive Failure

malaria vaccine

Story at-a-glance

  • Starting in 2018, GlaxoSmithKline’s (GSK) RTS,S (Mosquirix) malaria vaccine will be given to some children living in Ghana, Kenya and Malawi


This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.


By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Service.